Page last updated: 2024-08-24

glucose, (beta-d)-isomer and cyclosporine

glucose, (beta-d)-isomer has been researched along with cyclosporine in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (23.08)18.2507
2000's3 (23.08)29.6817
2010's6 (46.15)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Hattori, T; Hayashi, K; Ito, M; Nagamatsu, T; Suzuki, Y1
Chaplin, D; Dawson, J; Geiger, T; Kunz, S; Nguyen, H; Rordorf-Adam, C; Towbin, H; Vosbeck, K; Zingel, O1
Bermudez, LE; Egawa, H; Esquivel, CO; Hayashi, M; So, SK; Tojimbara, T1
Barbin, L; Cariani, A; Dovigo, L; Fabbri, E; Muccinelli, M; Spisani, S; Trotta, F1
Kamperdick, C; Lien, TP; Ninh, PT; Sung, TV; Thao, TT; Thuy, TT1
Ikeda, K; Shimizu, Y; Sugahara, S; Yamamoto, S1
Aliprantis, A; Glimcher, LH; Greenblatt, MB; Hu, B1
Bian, HN; Brunk, UT; Song, R; Wang, X; Zhao, KS; Zhao, M1
Ariyawansa, J; Curtin, C; Devineni, D; Di Prospero, NA; Mamidi, RN; Murphy, J; Rothenberg, P; Stieltjes, H; Vaccaro, N; Wajs, E; Wang, SS; Weiner, S1
Li, P; Song, R; Wang, X; Zhao, KS; Zhao, M1
Borowiec, A; Dadlez, M; Hryniewiecka, E; Jaźwiec, R; Pączek, L; Pawłowska, E; Tszyrsznic, W; Zegarska, J; Żochowska, D1
Han, X; He, M; Li, X; Pi, J; Sun, Y; Tian, W; Xu, J; Xu, S; Yu, R1
Barzaghi, F; Carletti, R; Castoldi, G; Colzani, M; di Gioia, CRT; Ippolito, S; Perseghin, G; Stella, A; Zatti, G; Zerbini, G1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and cyclosporine

ArticleYear
Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.
    International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:2

    Topics: Adult; Canagliflozin; Cyclosporine; Drug Interactions; Female; Glucosides; Humans; Male; Probenecid; Rifampin; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes

2015

Other Studies

12 other study(ies) available for glucose, (beta-d)-isomer and cyclosporine

ArticleYear
Acteoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent (2): Effect of acteoside on leukocyte accumulation in the glomeruli of nephritic rats.
    Japanese journal of pharmacology, 1994, Volume: 66, Issue:1

    Topics: Animals; Cyclosporine; gamma-Globulins; Glomerulonephritis; Glucosides; Immunohistochemistry; Immunosuppressive Agents; Kidney Glomerulus; Leukocyte Count; Leukocytes; Male; Phenols; Plants, Medicinal; Proteinuria; Rats; Rats, Sprague-Dawley

1994
Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. II. Identification of (tissue) macrophages as the IL-1 producing cells and the effect of anti-inflammatory drugs.
    Agents and actions, 1993, Volume: 38, Issue:3-4

    Topics: Animals; Cyclosporine; Diffusion Chambers, Culture; Dinoprostone; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Granuloma; Indomethacin; Inflammation; Interleukin-1; Macrophages; Mice; Pertussis Vaccine; Polymerase Chain Reaction; Prednisolone; RNA, Messenger; Zymosan

1993
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro.
    Transplantation proceedings, 1996, Volume: 28, Issue:3

    Topics: Animals; Cells, Cultured; Cyclosporine; Immunosuppressive Agents; Kupffer Cells; Macrophage Activation; Male; Rats; Rats, Wistar; Superoxides; Tacrolimus; Tumor Necrosis Factor-alpha; Zymosan

1996
Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms.
    Rheumatology (Oxford, England), 2001, Volume: 40, Issue:7

    Topics: Binding, Competitive; Calcium; Caseins; Cell Degranulation; Cell Survival; Chemotaxis; Cyclosporine; Dose-Response Relationship, Drug; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Peptide; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate; Zymosan

2001
Immunosuppressive auronol glycosides from Artocarpus tonkinensis.
    Die Pharmazie, 2004, Volume: 59, Issue:4

    Topics: Artocarpus; Benzofurans; Catechin; Cyclosporine; Glucosides; Glycosides; Humans; Immunosuppressive Agents; In Vitro Techniques; Indicators and Reagents; Lymphocytes; Magnetic Resonance Spectroscopy; Plant Extracts; Plant Leaves; Spectrometry, Mass, Electrospray Ionization

2004
Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
    European journal of pharmacology, 2006, Nov-21, Volume: 550, Issue:1-3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Anti-Inflammatory Agents; Carrageenan; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclosporine; Dermatitis, Contact; Edema; Erythrocytes; Fumarates; Hypersensitivity, Delayed; Immunosuppressive Agents; Indoles; Inflammation; Male; Mice; Mice, Inbred BALB C; Peritonitis; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sheep; Sulfonamides; Toluene 2,4-Diisocyanate; Zymosan

2006
Calcineurin regulates innate antifungal immunity in neutrophils.
    The Journal of experimental medicine, 2010, May-10, Volume: 207, Issue:5

    Topics: Animals; Antifungal Agents; beta-Glucans; Calcineurin; Candida albicans; Candidiasis; Cyclosporine; Disease Susceptibility; Homeostasis; Humans; Immunity, Innate; Immunosuppressive Agents; Mice; Mycoses; Neutrophils; Polysaccharides, Bacterial; Zymosan

2010
Polydatin, a natural polyphenol, protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Volume: 302, Issue:7

    Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cyclosporine; Cytoprotection; Glucosides; KATP Channels; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria, Muscle; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Smooth Muscle; Norepinephrine; Rats; Resveratrol; Shock, Hemorrhagic; Stilbenes

2012
Polydatin protects hepatocytes against mitochondrial injury in acute severe hemorrhagic shock via SIRT1-SOD2 pathway.
    Expert opinion on therapeutic targets, 2015, Volume: 19, Issue:7

    Topics: Animals; Cyclosporine; Disease Models, Animal; Glucosides; Hepatocytes; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Resveratrol; Shock, Hemorrhagic; Sirtuin 1; Stilbenes; Superoxide Dismutase

2015
Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients.
    Annals of transplantation, 2015, Aug-20, Volume: 20

    Topics: Adult; Bacterial Infections; Cyclosporine; Female; Glucosides; Glucuronides; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Transplant Recipients

2015
[Role of mitochondrial permeability transition pore in mediating the inhibitory effect of gastrodin on oxidative stress in cardiac myocytes
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018, Nov-30, Volume: 38, Issue:11

    Topics: Adenosine Triphosphate; Apoptosis; Benzyl Alcohols; Caspase 3; Cell Line; Cell Survival; Cyclosporine; Cytochromes c; Glucosides; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species

2018
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy.
    Acta diabetologica, 2021, Volume: 58, Issue:8

    Topics: Animals; Benzhydryl Compounds; Blood Pressure; Cyclosporine; Fibrosis; Glucosides; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2021